D.A. García-Herrera, C.L. Vázquez-Niño, R. Gutiérrez-Rosales, M.A. Aragón-Castro, G. Ruvalcaba-Oceguera
{"title":"Hipogonadismo de inicio tardío: revisión de conceptos y pautas diagnósticas","authors":"D.A. García-Herrera, C.L. Vázquez-Niño, R. Gutiérrez-Rosales, M.A. Aragón-Castro, G. Ruvalcaba-Oceguera","doi":"10.1016/j.uromx.2015.11.001","DOIUrl":null,"url":null,"abstract":"<div><p>Late-onset hypogonadism is a clinical and biochemical syndrome that is increasingly more frequent in the adult male population. However, it is rarely diagnosed and therefore goes untreated in the majority of affected men. The association between age-related testosterone deficiency and late-onset hypogonadism continues to be a subject of debate and its relation to symptoms such as loss of muscle strength and volume, loss of libido, erectile dysfunction, and changes in affective and emotional statuses of the patient are insidious, given that the symptomatology is often attributed to the “normal” aging process or other comorbidities of the patient. The diagnosis of late-onset hypogonadism is based on the coexistence of low total or free testosterone serum levels and symptoms suggestive of hypogonadism. Even though screening questionnaires directed at patients with clinical suspicion of the disease have been developed for late-onset hypogonadism, their diagnostic sensitivity and specificity is limited. Accurate and opportune diagnosis is vitally important because it enables testosterone levels to be reestablished and significant clinical improvement to be made through androgen replacement therapy.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.11.001","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista mexicana de urologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2007408515001408","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Late-onset hypogonadism is a clinical and biochemical syndrome that is increasingly more frequent in the adult male population. However, it is rarely diagnosed and therefore goes untreated in the majority of affected men. The association between age-related testosterone deficiency and late-onset hypogonadism continues to be a subject of debate and its relation to symptoms such as loss of muscle strength and volume, loss of libido, erectile dysfunction, and changes in affective and emotional statuses of the patient are insidious, given that the symptomatology is often attributed to the “normal” aging process or other comorbidities of the patient. The diagnosis of late-onset hypogonadism is based on the coexistence of low total or free testosterone serum levels and symptoms suggestive of hypogonadism. Even though screening questionnaires directed at patients with clinical suspicion of the disease have been developed for late-onset hypogonadism, their diagnostic sensitivity and specificity is limited. Accurate and opportune diagnosis is vitally important because it enables testosterone levels to be reestablished and significant clinical improvement to be made through androgen replacement therapy.
期刊介绍:
Revista Mexicana de Urología (RMU) [Mexican Journal of Urology] (ISSN: 0185-4542 / ISSN electronic: 2007-4085) is bimonthly publication that disseminates research by academicians and professionals of the international medical community interested in urological subjects, in the format of original articles, clinical cases, review articles brief communications and letters to the editor. Owing to its nature, it is publication with international scope that disseminates contributions in Spanish and English that are rigorously reviewed by peers under the double blind modality. Neither journalistic documents nor those that lack rigorous medical or scientific support are suitable for publication.